Karyopharm Therapeutics Inc (KPTI) — Cash Flow Quality Index

Latest as of June 2024: -1.62x

Karyopharm Therapeutics Inc (KPTI) has a Cash Flow Quality Index of -1.62x as of June 2024. Operating cash flow of $-38.50 Million is below net income of $23.79 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Karyopharm Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.62x

Operating CF / Net Income

Operating Cash Flow

$-38.50 Million

USD

Net Income

$23.79 Million

USD

Data as of

Jun 2024

Most recent filing

Annual Cash Flow Quality Index for Karyopharm Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Karyopharm Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.